University of Patras
Ανάπτυξη μεθόδου για τη δημιουργία αλλογενούς και ξενογενούς καρδιάς σε χιμαιρικούς μύες
Abstract
dc:descriptionThousands of people worldwide suffer from some form of end-stage organ failure. For these patients, transplantation is the only available therapy. However, the ever-widening gap between organ supply and demand is a huge problem in implementing this treatment. Over the last decade, the field of Regenerative Medicine has been trying to provide a solution for the organ shortage crisis by combining genome editing techniques with stem cell research. Many research groups are trying to generate allogeneic and xenogeneic organs through the production of chimeric embryos. The final goal is the generation of personalised human organs in large livestock animals.A large proportion of the transplants needed are hearts. For this reason, Dr. Papanayotou’s laboratory is developing a novel method for the in vivo generation of whole hearts, using two technologies, blastocyst complementation and tetraploid aggregation, together with novel genetic engineering techniques (CRISPR/Cas9).First, we developed a method for stable transfection of DNA sequences into the endogenous Hipp11 locus of mESCs. We used the CRISPR/Cas9 technology and specific plasmids, which impart red fluorescence to the transfected cells. We showed that our plasmids integrate into one of the two alleles of Hipp11. In order for our different mESC lines to segregate during development into heart and non-heart tissues, we needed a regulatory element that plays a key role in the early stages of cardiogenesis. We chose the enhancer AR1 of the cardiac marker Nkx2.5. This gene is expressed in the early stages of cardiogenesis and is regulated by AR1, which is activated dynamically and specifically only in the heart field and in cardiomyocytes. We therefore introduced the cardiac- specific enhancer ΑR1 into our plasmids and studied its activity during the differentiation of cardiomyocytes. We used the AR1 sequence with the highest activity and found that its two GATA binding sites play a key role in the activation and function of AR1 in Nkx2.5 expression.We then proceeded to construct suitable plasmids for the generation of allogeneic hearts. These plasmids impart fluorescence to the transfected mESCs and contain elements that exclude host cells from the heart field and donor cells from the rest of the developing body. The ability to eliminate each group from tissues of our choice was based on the cardiac enhancer AR1 and the diphtheria toxin gene, which when activated causes cell death.After constructing the necessary plasmids, we produced four cell lines, two Donor and two Host, which generate a red fluorescent heart and impart green fluorescence to the other tissues, respectively. In vitro analysis of these cell populations following their differentiation into cardiomyocytes showed that the Donor and Host cell lines function properly and can be introduced into tetraploid blastocysts. Finally, in vivo experiments performed with some of these plasmids gave us the expected phenotype, indicating the feasibility of our endeavour. Hopefully, this particular effort will be a stepping stone in the long-term effort of many research groups to create personalised human transplants into livestock animals. The methodology that we propose, with minor modifications, could be used in the future for the production of many other organs.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Founta, Konstantina-Maria
- Φούντα, Κωνσταντίνα-Μαρία
Subjects
dc:subject × 20- Καρδιά
- Χίμαιρα
- Βλαστοκύτταρα
- Βλαστοκύτταρα, Εμβρυονικά
- Βλαστοκύστη
- Γονιδιακή κλωνοποίηση
- Αναγεννητική ιατρική
- Heart transplantation, Complications
- Chimera
- Stem cells
- Blastocysts
- Blastocyst complementation
- Cloning
- Regenerative medicine
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Βασική ιατρική, άλλοι τομείς
- Basic Medicine
- Medical and Health Sciences
- Basic medicine, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52855